Should — I Buy Cvs Stock

: Ongoing antitrust scrutiny of pharmacy benefit managers (PBMs) and potential changes to Medicare Advantage rates remain key risks for the 2027 fiscal year.

Some analysts project a 12-month price target averaging , implying over 20% upside. should i buy cvs stock

The company has increased its dividend by 33% since 2022 and currently pays annually. : Ongoing antitrust scrutiny of pharmacy benefit managers

: While 2026 rates were better than feared, fluctuating Medicare reimbursement and higher medical utilization costs can squeeze insurance margins. should i buy cvs stock